WestEnd Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
WestEnd Advisors's LLY Position: Q2 2026 in Review
WestEnd Advisors increased its Eli Lilly (LLY) stake by 9.1% in Q2 2026, buying an estimated $2.04K and bringing the position to 24 shares worth $28.8K. The position accounts for ﹤0.01% of the portfolio, ranked #69.
WestEnd Advisors first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- WestEnd Advisors held 24 shares of Eli Lilly worth $28.8K as of Q2 2026.
- WestEnd Advisors bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
- Eli Lilly made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #69 holding.
- WestEnd Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.